ĐÁNH GIÁ KẾT QUẢ ĐIỀU TRỊ BỆNH LÝ ĐỤC THỦY TINH THỂ KÈM LOẠN THỊ GIÁC MẠC BẰNG PHẪU THUẬT PHACO KẾT HỢP RẠCH GIÁC MẠC VÙNG RÌA

Abstract

Objectives: Describe  the  clinical,  paraclinical and evaluate the treatment outcomes of cataract with corneal astigmatism using phacoemulsification combined with limbal relaxing incisions. Materials and method: A descriptive cross-sectional prospective study. The study included 41 eyes of cataract patients aged ≥18 years with regular corneal astigmatism ≥1D who underwent phacoemulsification combined with limbal relaxing incisions using an LRI knife at Hanh Phuc General Hospital in An Giang, from May 2024 to the end of March 2025.Results: The patients had an average age of 65.73 ± 9.526 years, 56.1% having grade III nuclear cataract hardness. After 1 month of treatment, the average corneal astigmatism was reduced to 0.63 ± 0.38D, and 100% achieved best spectacle-corrected visual acuity at a good level according to the WHO classification, and at 3 months post-treatment, 95.1% reported comfort. There was a statistically significant difference in LogMAR Uncorrected visual acuity (UCVA) and Best spectacle corrected visual acuity (BSCVA) from 1 month compared to 1 week after treatment (p<0.05). Conclusion: Phacoemulsification combined with limbal relaxing incisions for the treatment of cataract with corneal astigmatism ≥1D is a safe and highly effective method.